2014;16(3):308-319. 34. Kirchhof P, Ammentorp B, Darius H, et al. Management of atrial brillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial brillation: primary results of the PREvention oF thromboemolic events European Registry in Atrial Fibrillation (PREFER in AF). Europace. 2014;16(1):6-14. 35. Ha AC, Singh N, Cox JL, et al. Oral anticoagulation for stroke prevention in Canadian practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry. Can J Cardiol. 2016;32(2):204-210. 36. Zubaid M, Rashed WA, Alsheikh-Ali AA, et al. Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial brillation in the Arab Middle East. Circ Cardiovasc Qual Outcomes. 2011;4(4):477-482. 37. Chiang C-E, Wu T-J, Ueng K-C, et al. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial brillation. J Formosan Medical Assoc. 2016;115(11):893-952. 38. Friberg L, Rosenqvist M, Lip GYH. Evaluation of risk strati cation schemes for ischaemic stroke and bleeding in 182 678 patients with atrial brillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33(12):1500-1510. 39. Mareedu RK, Abdalrahman IB, Dharmashankar KC, et al. Atrial utter versus atrial brillation in a general population: differences in comorbidities associated with their respective onset. Clin Med Res. 2010;8(1):1-6. 40. Potpara TS, Lip GY. Lone atrial brillation an overview. Int J Clin Pract. 2014;68(4):418-433. 41. Granada J, Uribe W, Chyou PH, et al. Incidence and predictors of atrial utter in the general population. J Am Coll Cardiol. 2000;36(7):2242-2246. 42. Pisters R, Lane DA, Marin F, Camm AJ, Lip GY. Stroke and thromboembolism in atrial brillation. Circ J. 2012;76(10): 2289-2304. 43. Ganesan AN, Chew DP, Hartshorne T, et al. 